Grifols Partnership is a contract development and manufacturing platform (CDMO) focused on added value injectable products (small molecules), with extensive international experience in the development and manufacturing of many types of sterile drug products, mainly in flexible bags. They are able to leverage the resources and experiences of the larger Grifols organization to provide significant value to their partners. Customers who have chosen Grifols as their CDMO range from local, medium-sized pharmaceutical companies, to global industry leaders, in the human and veterinary sectors. Grifols Partnership is part of Grifols, a global company that — since 1909 — has enhanced the health and well-being of people around the world. Grifols develops, produces and markets innovative solutions and services in more than 100 countries.